defici arginin esteras cystic fibrosi pancrea demonstr proteolyt natur activ proteolyt activ defin hydrolysi peptid bond involv carboxyl group larginin plasma patient cystic fibrosi heterozygot control subject ha assay use fluorometr method protamin substrat fluorescamin reagent mean total proteolyt activ plasma patient cystic fibrosi wa approxim onehalf mean total activ control subject heterozygot mean proteolyt activ inhibit soybean trypsin inhibitor plasma patient cystic fibrosi wa approxim onethird control subject heterozygot relationship arginin esteras activ proteolyt activ wa investig ph optimum action revers irrevers inhibitor similar activ suggest arginin esteras activ proteolyt activ repres similar catalyt entiti find consist hypothesi basic defect cystic fibrosi may resid defici proteolyt enzym result accumul variou cation macromolecular factor describ investig serum patient cystic fibrosi demonstr defici proteolyt activ assay hydrolysi protamin cation polypeptid could explain presenc ciliotox cation protein polypeptid factor serum patient cystic fibrosi may unknown manner relat clinic manifest diseas